The FDA advisory panel recommended that compounding pharmacies be allowed to manufacture certain peptides, including BPC-157 and KPV, after a narrow vote.[5301585][5326333] The move is a win for peptide proponents and health secretary Robert F. Kennedy Jr., who has advocated for the use of these compounds in treating various conditions.[5301585][5326333] However, it's worth noting that the FDA will ultimately decide whether to lift current restrictions on these peptides and make them more easily accessible to people who have been turning to them to improve their health.[5301585][5326333] Meanwhile, Merck has reached voluntary licensing deals with seven companies to make generic versions of an experimental HIV prevention pill in 129 low- and middle-income countries.[5387733] The agreements will allow the manufacturers to sell generic versions of the medicine, known as alimatravir, to both public and private buyers, making it easier for the medicine to become available to the widest possible population.[5387733] The deals are royalty free, which makes it easier for the generic companies to predict costs.[5387733]